NVO

Novo Nordisk

Exchange: NYSESector: HealthcareIndustry: Biotechnology

Values in USD · ADR · Reports in DKK

Novo Nordisk is a leading global health care company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years. This heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and do business in a financially, socially, and environmentally responsible way.

Current Price

—

GoodMoat Value

$87.03

Profile

Valuation (TTM)

Market Cap—

P/E—

EV—

P/B—

Shares Out—

P/Sales—

Revenue—

EV/EBITDA—

Novo Nordisk (NVO) Quality Analysis

NVO GoodMoat Verdict

Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.

Run Stock X-Ray →

NVO Profitability

Profitability trend analysis coming soon

NVO Growth

Growth trend analysis coming soon

NVO Financial Health

Financial health indicators coming soon

NVO Quality & Fundamental Analysis

Novo Nordisk (NVO) is a Healthcare company in the Biotechnology industry, listed on NYSE. This quality analysis page evaluates Novo Nordisk's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.

Novo Nordisk has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency..

GoodMoat's quality analysis uses AI-powered insights to evaluate whether Novo Nordisk is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.